BioCentury
ARTICLE | Clinical News

Eniluracil: Phase I/II suspended enrollment

November 24, 2008 8:00 AM UTC

Adherex closed enrollment in a dose-escalation, Asian Phase I/II trial after a reprioritization of its development programs. The trial, which had enrolled 9 patients, is evaluating oral eniluracil in ...